SCHEMBL6707952

SCHEMBL6707952

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)c4ccc(-c5ccccc5)cc4)c3[nH]2)c(-c2nnn[nH]2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS12 P56730 1/20 0.39
KMT2A Q03164 2/20 0.39
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
NR1H4 Q96RI1 2/20 0.36
PLAU P00749 3/20 0.36
F2 P00734 1/20 0.36
PLG P00747 1/20 0.36
KLKB1 P03952 1/20 0.36
PRSS1 P07477 1/20 0.36
MEN1 O00255 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
SERPINE1 P05121 1/20 0.36
NSD2 O96028 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
MAPK14 Q16539 1/20 0.36
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710250 0.96 KMT2A (0.42) PRSS12KMT2ANPC1RAB9ANR1H4
SCHEMBL6709197 0.92 IRAK4 (0.42) KMT2ANPC1RAB9ANR1H4PLAU
SCHEMBL6713731 0.92 PARP14 (0.41) KMT2ANR1H4MEN1PPARGPPARD
SCHEMBL6712030 0.91 CHRNB2 (0.41) NR1H4RXFP1NSD2PPARG
SCHEMBL6713312 0.91 TDP1 (0.38) KMT2ANPC1RAB9ANR1H4MEN1
SCHEMBL6710254 0.90 NPC1 (0.40) NPC1RAB9A
SCHEMBL6713373 0.89 RXFP1 (0.40) KMT2ANPC1RAB9AMEN1RXFP1
SCHEMBL6916001 0.89 PARP14 (0.42) KMT2APLAUF2PLGKLKB1
SCHEMBL6710380 0.89 MAP3K5 (0.43) KMT2ANPC1RAB9ANR1H4MEN1
SCHEMBL6707788 0.88 TDP1 (0.41) KMT2ANPC1RAB9AMEN1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PRSS12 3950/4885KMT2A 3181/4885MAOA 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.